Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juan A. Merchan"'
Publikováno v:
Endocrine Practice. 25:211-212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d9b63b67fec3b455961241c8aa9c67c
https://doi.org/10.1016/s1530-891x(20)46785-0
https://doi.org/10.1016/s1530-891x(20)46785-0
Autor:
Rogelio González Sarmiento, Ignacio Cruz-González, Ana Martin Garcia, Cándido Martín Luengo, Irene Rodriguez Hernandez, Ana Cordero Vaquero, Juan Rama Merchan
Publikováno v:
Journal of the American College of Cardiology. 60(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b180b1d3d92dfe080d2d5beae4c8f757
Autor:
Marcy Silver, Mary Gavin, Juan A. Merchan, Ryuichi Aikawa, Tengiz Tkebuchava, Sabyasachi Sen, Jarrod Dean, Masaaki, Young Sup Yoon, John E.J. Rasko
Publikováno v:
Human gene therapy. 21(10)
The regenerative potential of bone marrow-derived endothelial progenitor cells (EPCs) has been adapted for the treatment of myocardial and limb ischemia via ex vivo expansion. We sought to enhance EPC function by the efficient genetic modification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca176d4f6b41a1167769240ba18420a
https://pubmed.ncbi.nlm.nih.gov/20497036
https://pubmed.ncbi.nlm.nih.gov/20497036
Publikováno v:
International Journal of Biomedical Science : IJBS
Vascular endothelial cells (EC) have been targeted for the treatment of pathological conditions such as atherosclerosis, hypercholesterolemia, post-angioplasty restenosis and hypertension. Non-pathogenic adeno-associated virus (AAV) has been shown as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c03416ff4d0db1a13821a06b54550af
https://pubmed.ncbi.nlm.nih.gov/23675093
https://pubmed.ncbi.nlm.nih.gov/23675093
Autor:
Marcia Silver, Juan A. Merchan, Douglas W. Losordo, Elizabeth Eaton, Tengiz Tkebuchava, Jarrod Dean, Mary Gavin, Sabyasachi Sen, Maasaki, Ryuichi Aikawa, Young Sup Yoon
Publikováno v:
Molecular Therapy. 13:S88
[bull]| Background- The regenerative potential of bone marrow-derived endothelial progenitor cells (EPCs) has been adapted for the treatment of myocardial and limb ischemia via ex vivo expansion. Biotechnologically, it is plausible to constitute a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19671deedcb7cce0b8b970986f2ae928
https://doi.org/10.1016/j.ymthe.2006.08.255
https://doi.org/10.1016/j.ymthe.2006.08.255